1. Home
  2. HOLO vs TCRX Comparison

HOLO vs TCRX Comparison

Compare HOLO & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroCloud Hologram Inc.

HOLO

MicroCloud Hologram Inc.

HOLD

Current Price

$1.62

Market Cap

43.3M

Sector

Technology

ML Signal

HOLD

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$0.80

Market Cap

49.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOLO
TCRX
Founded
2018
2018
Country
China
United States
Employees
74
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
49.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HOLO
TCRX
Price
$1.62
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.00
AVG Volume (30 Days)
284.6K
644.9K
Earning Date
08-10-2023
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.28
EPS
N/A
N/A
Revenue
N/A
$10,325,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$19.81
P/E Ratio
$0.16
N/A
Revenue Growth
N/A
266.65
52 Week Low
$1.43
$0.72
52 Week High
$7.03
$2.57

Technical Indicators

Market Signals
Indicator
HOLO
TCRX
Relative Strength Index (RSI) 47.85 39.31
Support Level $1.43 N/A
Resistance Level $1.69 $1.16
Average True Range (ATR) 0.10 0.06
MACD 0.01 -0.01
Stochastic Oscillator 32.00 18.58

Price Performance

Historical Comparison
HOLO
TCRX

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc provides holographic technology services. Its services include holographic light detection and ranging (LiDAR) solutions, holographic LiDAR point cloud algorithms architecture design, technical holographic imaging solutions, holographic LiDAR sensor chip design, and holographic vehicle intelligent vision technology to service customers that provide holographic driver assistance systems (ADAS). The company also provides holographic digital twin technology services for customers and has built a proprietary holographic digital twin technology resource library. MicroCloud's operating segments are: Holographic technology service, which generates maximum revenue, and Holographic solutions. Its revenues are mainly generated in the People's Republic of China (PRC).

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Share on Social Networks: